Market conditions weaken, impacting earnings and revenue

  • Thermo Fisher reduces full-year outlook for 2023
  • Adjusted earnings expected to be $21.50 per share
  • Revenue projected to be $42.7 billion
  • Core organic revenue expected to rise 1%

Thermo Fisher, the scientific-equipment company based in Waltham, Mass., has revised its full-year outlook for 2023 due to further weakening of market conditions in the third quarter. The company now expects adjusted earnings of $21.50 per share, down from the previous forecast of $22.28 to $22.72 per share. Additionally, revenue is projected to be $42.7 billion, a decrease from the previous guidance of $43.4 billion to $44 billion. However, core organic revenue, which excludes Covid-19 testing revenue and the effects of acquisitions and foreign currency translation, is anticipated to rise by 1%.

Public Companies: Thermo Fisher (N/A)
Private Companies:
Key People:

Factuality Level: 8
Justification: The article provides specific information about Thermo Fisher reducing its revenue and adjusted earnings outlook for 2023 due to weakened market conditions in the third quarter. The article includes specific figures for the adjusted earnings and revenue projections. It also mentions core organic revenue and its expected increase of 1%. The information provided seems factual and does not contain any obvious bias or misleading information.

Noise Level: 8
Justification: The article provides relevant information about Thermo Fisher reducing its revenue and adjusted earnings outlook for 2023 due to weakened market conditions. It includes specific figures and projections. However, it lacks in-depth analysis, antifragility considerations, and accountability of powerful people. It also does not provide actionable insights or solutions.

Financial Relevance: Yes
Financial Markets Impacted: Thermo Fisher’s reduced revenue and adjusted earnings outlook may impact the company’s stock price and investor sentiment.

Presence of Extreme Event: No
Nature of Extreme Event: No
Impact Rating of the Extreme Event: No
Justification: The article provides information about Thermo Fisher’s financial outlook, which is relevant to financial markets and investors. However, there is no mention of an extreme event or its impact.